Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Real-world evidence highlights baricitinib's effectiveness and safety for treating atopic dermatitis and alopecia areata, showing high patient satisfaction and significant improvements.

Real-World Data Support Baricitinib Use for Atopic Dermatitis, Alopecia

In this retrospective study, investigators highlight the effectiveness and safety of baricitinib and systemic corticosteroid addition for alopecia areata.

Systemic Corticosteroids Enhance Baricitinib’s Efficacy for Alopecia Areata

These findings highlight the potential for JAKi use in alopecia areata in terms of associated neuroimmune dysregulation and comorbidities.

JAK Inhibitor Use Improves Psychiatric, Sleep Outcomes in Alopecia Areata

Notable psychosocial and occupational burdens, as well as impairments to emotional well-being, were seen among caregivers of adolescents with alopecia.

Study Highlights Psychosocial Burden on Caregivers of Adolescents with Alopecia Areata

In this analysis, investigators highlight the efficacy and safety of azathioprine as a monotherapy for those with recalcitrant and severe alopecia areata.

Azathioprine Effective for Patients with Recalcitrant, Severe Alopecia Areata

In this iteration of our Month in Review series, we highlight some of the most notable stories covered in April in the dermatology field.

Dermatology Month in Review: April 2025

This analysis was a single-center retrospective cohort study, with investigators highlighting an underrecognized alopecia pattern.

Study Identifies Underrecognized Alopecia Variant Titled ‘Macular Alopecia’

This announcement by Q32 Bio Inc. highlights the Fast Track designation by the FDA granted to bempikibart (ADX-914) for alopecia areata.

FDA Grants Fast Track Designation to Bempikibart for Alopecia Areata

These data were the conclusion of a case series highlighting the experiences and responses of African American patients with alopecia areata who utilize JAK inhibitors.

Experiences with JAK Inhibitors Highlighted Among Black Patients with Alopecia Areata

These findings point to a need for evidence-based digital health information access to counter misinformation regarding androgenetic alopecia.